Literature DB >> 10998438

Expression of cyclooxygenase-1 and -2 mRNA in rat tissues: tissue-specific difference in the expression of the basal level of mRNA.

T Okamoto1, O Hino.   

Abstract

The expression of cyclooxygenase (Cox)-1 and -2 mRNA was studied in tissues of Fisher 344 (F344) (n=3) and Brown Norway (BN) (n=3) strain rats using the reverse transcription polymerase chain reaction. Cox-1 mRNA was expressed in the liver, kidney and lung, but not in the heart. Cox-2 mRNA was expressed in the kidney, heart and lung, but not in the liver. The present results showed the differential expression of basal Cox-1 and Cox-2 mRNA in the rat tissues, suggesting that Cox-1 and Cox-2 may contribute to the regulation of normal pathophysiological conditions in a tissue-specific manner. Thus, it is desirable to perform mapping of the basal expression of Cox-1 and Cox-2 in specific organs in the body in order to anticipate the effects of non-steroidal anti-inflammatory drugs on normal pathophysiological conditions. Finally, no difference was observed between F344 and BN rat tissues in the levels of Cox-1 and Cox-2 mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998438     DOI: 10.3892/ijmm.6.4.455

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

1.  PAMAM dendrimers as nano carriers to investigate inflammatory responses induced by pulmonary exposure of PCB metabolites in Sprague-Dawley rats.

Authors:  Orarat Wangpradit; Andrea Adamcakova-Dodd; Katharina Heitz; Larry Robertson; Peter S Thorne; Gregor Luthe
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-24       Impact factor: 4.223

2.  Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.

Authors:  Ryan T Dackor; Jennifer Cheng; James W Voltz; Jeffrey W Card; Catherine D Ferguson; Ryan C Garrett; J Alyce Bradbury; Laura M DeGraff; Fred B Lih; Kenneth B Tomer; Gordon P Flake; Gregory S Travlos; Randle W Ramsey; Matthew L Edin; Daniel L Morgan; Darryl C Zeldin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-19       Impact factor: 5.464

3.  Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration.

Authors:  Surya P Ayalasomayajula; Uday B Kompella
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

4.  Combined Effects of PVT1 and MiR-146a Single Nucleotide Polymorphism on the Lung Function of Smokers with Chronic Obstructive Pulmonary Disease.

Authors:  Sijing Zhou; Yi Liu; Min Li; Peipei Wu; Gengyun Sun; Guanghe Fei; Xuan Xu; Xuexin Zhou; Luqian Zhou; Ran Wang
Journal:  Int J Biol Sci       Date:  2018-06-23       Impact factor: 6.580

5.  Radiosynthesis and Preclinical Evaluation of 11C-VA426, a Cyclooxygenase-2 Selective Ligand.

Authors:  Assunta Carpinelli; Paolo Rainone; Sara Belloli; Annalisa Reale; Andrea Cappelli; Giuliani Germano; Valentina Murtaj; Angela Coliva; Giuseppe Di Grigoli; Angela Valeri; Maria Carla Gilardi; Luigi Gianolli; Maurizio Anzini; Rosa Maria Moresco
Journal:  Contrast Media Mol Imaging       Date:  2019-09-24       Impact factor: 3.161

6.  Allelic variation in the canine Cox-2 promoter causes hypermethylation of the canine Cox-2 promoter in clinical cases of renal dysplasia.

Authors:  Mary H Whiteley
Journal:  Clin Epigenetics       Date:  2014-04-03       Impact factor: 6.551

7.  Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease.

Authors:  Ran Wang; Min Li; Sijing Zhou; Daxiong Zeng; Xuan Xu; Rui Xu; Gengyun Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-04

8.  PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model.

Authors:  Ole Tietz; Melinda Wuest; Alison Marshall; Darryl Glubrecht; Ingrit Hamann; Monica Wang; Cody Bergman; Jenilee D Way; Frank Wuest
Journal:  EJNMMI Res       Date:  2016-04-26       Impact factor: 3.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.